BIOMARIN PHARMACEUTICAL INC Operating Cash Flow
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Operating Cash Flow of $388.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $168.11M, a 9.26% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $220.65M, a 26.52% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $99.64M, a 46.32% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $368.69M, a 66.46% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for fiscal 2025 was $827.99M, a 44.54% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for fiscal 2024 was $572.84M, a 259.69% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for fiscal 2023 was $159.26M, a 9.46% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC net cash provided by (used in) operating activities for fiscal 2022 was $175.90M, a 42.24% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $168.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $388.76M 10-Q · filed 2026-08-06 | $488.40M derived: sum of 3 quarters · filed 2026-08-06 | $857.09M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $220.65M 10-Q · filed 2026-05-05 | $320.30M derived: sum of 2 quarters · filed 2026-05-05 | $688.98M derived: sum of 3 quarters · filed 2026-05-05 | $874.25M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $99.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $468.33M derived: sum of 2 quarters · filed 2026-02-26 | $653.60M derived: sum of 3 quarters · filed 2026-08-06 | $827.99M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $368.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $553.96M derived: sum of 2 quarters · filed 2026-08-06 | $728.35M 10-Q · filed 2025-10-28 | $913.98M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $185.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $359.67M 10-Q · filed 2026-08-06 | $545.29M derived: sum of 3 quarters · filed 2026-08-06 | $766.77M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $174.39M 10-Q · filed 2026-05-05 | $360.02M derived: sum of 2 quarters · filed 2026-05-05 | $581.50M derived: sum of 3 quarters · filed 2026-05-05 | $700.26M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $185.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $407.11M derived: sum of 2 quarters · filed 2026-02-26 | $525.87M derived: sum of 3 quarters · filed 2026-02-26 | $572.84M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $221.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $340.24M derived: sum of 2 quarters · filed 2025-10-28 | $387.21M 10-Q · filed 2025-10-28 | $414.70M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $118.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $165.73M 10-Q · filed 2025-08-05 | $193.22M derived: sum of 3 quarters · filed 2026-02-26 | $328.86M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $46.97M 10-Q · filed 2025-05-02 | $74.45M derived: sum of 2 quarters · filed 2026-02-26 | $210.10M derived: sum of 3 quarters · filed 2026-02-26 | $280.16M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $27.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $163.13M derived: sum of 2 quarters · filed 2026-02-26 | $233.19M derived: sum of 3 quarters · filed 2026-02-26 | $159.26M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $135.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $205.71M derived: sum of 2 quarters · filed 2024-10-31 | $131.78M 10-Q · filed 2024-10-31 | $138.56M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-06-30 | $70.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$3.87M 10-Q · filed 2024-08-05 | $2.92M derived: sum of 3 quarters · filed 2025-02-24 | $161.24M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-03-31 | -$73.93M 10-Q · filed 2024-04-26 | -$67.15M derived: sum of 2 quarters · filed 2025-02-24 | $91.17M derived: sum of 3 quarters · filed 2025-02-24 | $147.40M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2022-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $165.11M derived: sum of 2 quarters · filed 2025-02-24 | $221.33M derived: sum of 3 quarters · filed 2025-02-24 | $175.90M 10-K · filed 2025-02-24 | |
| 2022-09-30 | $158.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $214.55M derived: sum of 2 quarters · filed 2023-11-02 | $169.12M 10-Q · filed 2023-11-02 | $180.30M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-06-30 | $56.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $10.79M 10-Q · filed 2023-08-02 | $21.98M derived: sum of 3 quarters · filed 2024-02-26 | $119.03M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-03-31 | -$45.43M 10-Q · filed 2023-04-28 | -$34.25M derived: sum of 2 quarters · filed 2024-02-26 | $62.81M derived: sum of 3 quarters · filed 2024-02-26 | $145.59M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2021-12-31 | $11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $108.24M derived: sum of 2 quarters · filed 2024-02-26 | $191.02M derived: sum of 3 quarters · filed 2024-02-26 | $304.54M 10-K · filed 2024-02-26 | |
| 2021-09-30 | $97.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $179.84M derived: sum of 2 quarters · filed 2022-10-28 | $293.36M 10-Q · filed 2022-10-28 | $279.97M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $82.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $196.30M 10-Q · filed 2022-08-04 | $182.91M derived: sum of 3 quarters · filed 2023-02-27 | $269.12M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $113.51M 10-Q · filed 2022-04-29 | $100.13M derived: sum of 2 quarters · filed 2023-02-27 | $186.33M derived: sum of 3 quarters · filed 2023-02-27 | $214.07M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | -$13.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $72.82M derived: sum of 2 quarters · filed 2023-02-27 | $100.56M derived: sum of 3 quarters · filed 2023-02-27 | $85.36M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $86.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $113.94M derived: sum of 2 quarters · filed 2021-10-29 | $98.75M 10-Q · filed 2021-10-29 | $156.09M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $27.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $12.54M 10-Q · filed 2021-07-30 | $69.89M derived: sum of 3 quarters · filed 2022-02-25 | $140.01M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | -$15.19M 10-Q · filed 2021-04-30 | $42.15M derived: sum of 2 quarters · filed 2022-02-25 | $112.27M derived: sum of 3 quarters · filed 2022-02-25 | $87.94M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $57.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $127.47M derived: sum of 2 quarters · filed 2022-02-25 | $103.13M derived: sum of 3 quarters · filed 2022-02-25 | $48.26M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $70.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $45.79M derived: sum of 2 quarters · filed 2020-11-06 | -$9.08M 10-Q · filed 2020-11-06 | $40.29M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$24.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$79.21M 10-Q · filed 2020-08-05 | -$29.83M derived: sum of 3 quarters · filed 2021-02-26 | $17.37M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$54.87M 10-Q · filed 2020-05-01 | -$5.49M derived: sum of 2 quarters · filed 2021-02-26 | $41.71M derived: sum of 3 quarters · filed 2021-02-26 | $7.85M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $49.37M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $96.57M derived: sum of 2 quarters · filed 2021-02-26 | $62.72M derived: sum of 3 quarters · filed 2021-02-26 | $20.21M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $47.20M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | $13.34M derived: sum of 2 quarters · filed 2019-11-04 | -$29.17M 10-Q/A · filed 2019-11-04 | -$14.55M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$33.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$76.37M 10-Q · filed 2019-08-02 | -$61.75M derived: sum of 3 quarters · filed 2020-02-27 | -$23.46M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$42.51M 10-Q · filed 2019-04-29 | -$27.89M derived: sum of 2 quarters · filed 2020-02-27 | $10.40M derived: sum of 3 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $14.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $52.91M derived: sum of 2 quarters · filed 2020-02-27 | -$8.76M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $38.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$23.37M 10-Q · filed 2018-10-26 | |||
| 2017-06-30 | -$61.66M 10-Q · filed 2018-08-03 | ||||
| 2016-12-31 | -$227.84M 10-K · filed 2019-02-28 | ||||
| 2014-03-31 | -$26.87M 10-Q · filed 2014-05-02 | -$38.17M derived: sum of 2 quarters · filed 2014-05-02 | -$47.66M derived: sum of 3 quarters · filed 2014-05-02 | -$54.48M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2013-12-31 | -$11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$20.79M derived: sum of 2 quarters · filed 2014-02-26 | -$27.61M derived: sum of 3 quarters · filed 2014-02-26 | -$59.63M 10-K · filed 2014-02-26 | |
| 2013-09-30 | -$9.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$16.31M derived: sum of 2 quarters · filed 2013-10-28 | -$48.34M 10-Q · filed 2013-10-28 | -$36.35M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2013-06-30 | -$6.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$38.85M 10-Q · filed 2013-07-29 | -$26.86M derived: sum of 3 quarters · filed 2014-05-02 | -$12.65M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2013-03-31 | -$32.03M 10-Q · filed 2014-05-02 | -$20.04M derived: sum of 2 quarters · filed 2014-05-02 | -$5.83M derived: sum of 3 quarters · filed 2014-05-02 | -$7.25M derived: sum of 4 quarters · filed 2014-05-02 | |
| 2012-12-31 | $11.99M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $26.20M derived: sum of 2 quarters · filed 2014-02-26 | $24.78M derived: sum of 3 quarters · filed 2014-02-26 | $17.61M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $14.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $12.79M derived: sum of 2 quarters · filed 2013-10-28 | $5.62M 10-Q · filed 2013-10-28 | $5.11M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-06-30 | -$1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$8.59M 10-Q · filed 2013-07-29 | -$9.10M derived: sum of 3 quarters · filed 2014-02-26 | -$243.00K derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-03-31 | -$7.17M 10-Q · filed 2013-04-29 | -$7.68M derived: sum of 2 quarters · filed 2014-02-26 | $1.18M derived: sum of 3 quarters · filed 2014-02-26 | $14.74M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2011-12-31 | -$513.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $8.35M derived: sum of 2 quarters · filed 2014-02-26 | $21.91M derived: sum of 3 quarters · filed 2014-02-26 | $18.41M 10-K · filed 2014-02-26 | $18.75M 10-K · filed 2012-02-22 |
| 2011-09-30 | $8.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $22.43M derived: sum of 2 quarters · filed 2012-10-29 | $18.93M 10-Q · filed 2012-10-29 | $3.15M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-06-30 | $13.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $10.07M 10-Q · filed 2012-08-02 | -$5.71M derived: sum of 3 quarters · filed 2013-02-26 | $3.34M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2011-03-31 | -$3.50M 10-Q · filed 2012-04-30 | -$19.28M derived: sum of 2 quarters · filed 2013-02-26 | -$10.22M derived: sum of 3 quarters · filed 2013-02-26 | $12.00M derived: sum of 4 quarters · filed 2013-02-26 | |
| 2010-12-31 | -$15.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$6.72M derived: sum of 2 quarters · filed 2013-02-26 | $15.50M derived: sum of 3 quarters · filed 2013-02-26 | $18.75M 10-K · filed 2013-02-26 | |
| 2010-09-30 | $9.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $31.28M derived: sum of 2 quarters · filed 2011-10-31 | $34.53M 10-Q · filed 2011-10-31 | $53.99M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-06-30 | $22.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $25.47M 10-Q · filed 2011-08-01 | $44.94M derived: sum of 3 quarters · filed 2012-02-22 | $73.37M derived: sum of 4 quarters · filed 2012-02-22 | |
| 2010-03-31 | $3.25M 10-Q · filed 2011-04-29 | $22.72M derived: sum of 2 quarters · filed 2012-02-22 | $51.15M derived: sum of 3 quarters · filed 2012-02-22 | ||
| 2009-12-31 | $19.47M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $47.90M derived: sum of 2 quarters · filed 2012-02-22 | $87.73M 10-K · filed 2012-02-22 | ||
| 2009-09-30 | $28.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $68.27M 10-Q · filed 2010-10-29 | |||
| 2009-06-30 | $39.83M 10-Q · filed 2010-08-04 | ||||
| 2008-12-31 | -$9.18M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |